According to functional analyses, the berberine mode of action in treating KIRC/COVID-19 may have diverse pathways that interfere with tumour cell proliferation or viral self-replication, particularly the PI3K-Akt signalling pathway. The gene discussed is AKT1; the disease is neoplasm.